NCT06277206View on ClinicalTrials.gov

A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

August 4, 2021

Primary Completion Date

November 19, 2023

Study Completion Date

February 10, 2024

Conditions
18F-FAPIPancreas AdenocarcinomaSystemic TreatmentPathologic Response
Interventions
DIAGNOSTIC_TEST

18F-FAPI PET/CT

Enrolled patients underwent 18F-FAPI PET/CT at diagnosis. And preoperative 18F-FAPI PET/CT was completed in the patients met the criteria for conversion surgery after systemic treatment. The correlation between changes of parameters before and after treatment and pathologic response was analyzed.

Trial Locations (1)

310003

First Affiliated Hospital, Medical College of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT06277206 - A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter